Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Browsing Category
GAO
GAO Reports Vulnerabilities in CMS Payment Oversight
In 2011, CMS estimated that Medicaid and Medicare had improper payments of $21.9 billion and almost $43 billion,…
GAO Report Drug Pricing: Research on Savings from Generic Drug Use
Since the Drug Price Competition and Patent Term Restoration Act of 1984—commonly known as the Hatch-Waxman Act—generic drugs have…
GAO Recommends the FDA to Strengthen Investigation Oversight
Within the Food and Drug Administration (FDA) is the Office of Criminal Investigations (OCI), which investigates individuals and…
GAO to FDA: Action Needed to Improve Timeliness on Clinical Investigator…
The Government Accounting Office ("GAO") published a new report on the oversight of clinical investigators titled,…